"A randomized, controlled trial comparing the immunogenicity of 2 doses vs 3 doses of the 9-valent HPV vaccine in females 27-45 years of age"

    Project: Other project

    Project Details

    StatusActive
    Effective start/end date8/31/22 → 8/30/26

    Funding

    • Cancer Prevention and Research Institute: $947,518.00